nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-39CC485D·Framework v5.5·Pipeline v0.4·Evaluated 04 Aug 2026·OECD: 3.1 Basic medicine·Subfield: Molecular Biology·Basis: Full text·Type: Laboratory experiment

Mechanism of ADP-Inhibited ATP Hydrolysis in Single Proton-Pumping FoF1-ATP Synthase Trapped in Solution.

Pérez et al.Pérez, Heitkamp, Börsch·2023·International journal of molecular sciences·10.3390/ijms24098442 ↗

Primary claim

ADP inhibition did not decrease the catalytic turnover of all FoF1-ATP synthases equally.

Supported · direct active-fraction and turnover data support the direction, with low-count and classification limits
In brief

A focused single-molecule study that clarifies ADP inhibition mechanics, constrained by analysis sensitivity in an engineered in vitro assay.

ReliabilityCaveats4 of 4 checks completeRead the entry ↓
Possible — the claim's weakest requirement is that the effect exists at all. Based on how the study was designed and conducted, not on statistics extracted from the paper. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

FoF1-ATP synthases in mitochondria, in chloroplasts, and in most bacteria are proton-driven membrane enzymes that supply the cells with ATP made from ADP and phosphate. Different control mechanisms exist to monitor and prevent the enzymes' reverse chemical reaction of fast wasteful ATP hydrolysis, including mechanical or redox-based blockade of catalysis and ADP inhibition. In general, product inhibition is expected to slow down the mean catalytic turnover. Biochemical assays are ensemble measurements and cannot discriminate between a mechanism affecting all enzymes equally or individually. For example, all enzymes could work more slowly at a decreasing substrate/product ratio, or an increasing number of individual enzymes could be completely blocked. Here, we examined the effect of increasing amounts of ADP on ATP hydrolysis of single Escherichia coli FoF1-ATP synthases in liposomes. We observed the individual catalytic turnover of the enzymes one after another by monitoring the internal subunit rotation using single-molecule Förster resonance energy transfer (smFRET). Observation times of single FRET-labeled FoF1-ATP synthases in solution were extended up to several seconds using a confocal anti-Brownian electrokinetic trap (ABEL trap). By counting active versus inhibited enzymes, we revealed that ADP inhibition did not decrease the catalytic turnover of all FoF1-ATP synthases equally. Instead, increasing ADP in the ADP/ATP mixture reduced the number of remaining active enzymes that operated at similar catalytic rates for varying substrate/product ratios.

Key Claims

Primary finding · Supported

ADP inhibition did not decrease the catalytic turnover of all FoF1-ATP synthases equally.

Possible — the claim's weakest requirement is that the effect exists at all. Based on how the study was designed and conducted, not on statistics extracted from the paper. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

direct active-fraction and turnover data support the direction, with low-count and classification limits

Abstract; Results §§2.3, 2.5; Figures 4, 7
Secondary · Supported

increasing ADP in the ADP/ATP mixture reduced the number of remaining active enzymes that operated at similar catalytic rates

active-enzyme percentage declines while turnover remains similar across interpretable ratios

Abstract; Results §2.5; Figure 7A,C
Secondary · Supported

For all conditions, the mean turnover calculated from each individual active enzyme was 88 ± 15 ATP/s.

consistent per-enzyme turnover summaries, excluding low-count high-ADP conditions

Results §2.3; Figure 4; Table S1
Secondary · Supported

the maximum percentage of active enzymes was 25% at low ADP content and dropped down to 8%

direct counting result, though active/inactive classification robustness limits precision

Results §2.5; Figure 7C
Secondary · Well-supported

our current observation times of single FoF1-ATP synthase did not allow us to measure the time constants

explicit limitation supported by comparable active and inactive duration distributions

Discussion §3; Results §2.4; Figure 6

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Mechanistic question cleanly isolated

The introduction frames a specific ambiguity that ensemble assays cannot resolve: whether ADP slows all enzymes or blocks individual enzymes. The single-molecule counting design directly targets that distinction by observing active and inactive FoF1-ATP synthases one at a time.

↳ Abstract; Introduction §1; Results §2.5

#methodological rigour

Systematic nucleotide-ratio experiment

The study examines 11 ADP/ATP ratios at fixed total nucleotide concentration and transparently excludes very low-count high-ADP conditions from interpretation. This gives the central comparison a structured experimental basis across the interpretable range.

↳ Results §2.3; Figure 4; Figure 7

#positioning

Limitations explicitly connected to future work

The discussion states that current trap times are not long enough to measure transient ADP-inhibited state kinetics and proposes concrete improvements, including quartz cells, oxygen scavengers, longer trapping, ε-CTD truncations, and nanodiscs. This makes the boundary between current evidence and next-step research clear.

↳ Discussion §3

Limitations

#methodological rigour

Classification fragile at zero ATP

At the 100/0 ADP/ATP condition, the HMM software assigned two enzymes with apparently fluctuating FRET efficiencies even though no ATP was present. The authors excluded these cases from interpretation, but the episode shows sensitivity in the state-classification pipeline near the low-ATP boundary.

↳ Results §2.3; Methods §4.3

#contribution

Temporal kinetics remain unresolved

The observed active and inactive periods often span similar 50–500 ms ranges and may be limited by photobleaching rather than true enzymatic switching. As a result, the study identifies a population-level active-fraction mechanism but cannot estimate rates of entering or leaving ADP inhibition.

↳ Results §2.4; Discussion §3

#application pathway

Transferability beyond assay is limited

The quantitative results come from a specific E. coli FoF1-ATP synthase construct, reconstituted liposomes, defined FRET labels, and low-ionic-strength ABEL-trap buffer. The paper does not demonstrate that the same active-fraction behavior or percentages hold in native membranes or other ATP synthases.

↳ Methods §4.1; Discussion §3

Does this match your read? Add your assessment ↓

Nabu Commentary

The central result is well supported across the interpretable ADP/ATP range: Figures 4 and 7 show broadly stable active-enzyme turnover alongside a falling active fraction as ADP increases. The craft score is tempered because Methods §4.3 relies on HMM idealization plus manual control, condition-specific histogram fit starting points, and a FRET-state-pair definition whose sensitivity is not deeply tested. Results §2.3 also reports software-assigned fluctuating traces at 100/0 ADP/ATP, which the authors exclude but which still signals low-ATP classification fragility. The discussion is unusually clear about limits, especially photobleaching and the inability to quantify transient inhibition/recovery kinetics.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.7±0.2

Contribution
3.9

The score reflects a meaningful mechanistic advance: the single-molecule design separates stable turnover among active enzymes from a falling active fraction as ADP rises. The contribution is narrowed by the E. coli liposome system and by the inability to measure inhibition and recovery kinetics directly.

Abstract; Results §§2.3, 2.5; Discussion §3

increasing ADP in the ADP/ATP mixture reduced the number of remaining active enzymes

Methodological Rigour
3.4

The ABEL-trap smFRET design is well matched to counting active versus inactive enzymes and includes systematic ADP/ATP variation plus ATP-only comparison. The score is limited by HMM classification sensitivity at 100/0 ADP/ATP, condition-dependent fit starting points, photobleaching-limited durations, and incomplete robustness analysis of active/inactive classification.

Methods §§4.1–4.3; Results §§2.3–2.5; Discussion §3

the 100/0 ADP/ATP ratio, two enzymes with apparently fluctuating FRET efficiencies were considered

Reporting
4.1

The manuscript lays out the biological question, assay logic, cross-condition results, and scope limits in a generally transparent sequence. Some analysis conventions, especially FRET-state-pair mapping and condition-specific fit windows, require careful reading and are less accessible to non-specialists.

Introduction §1; Results §§2.2–2.5; Methods §4.3

A full rotation was defined as a pair of high and medium FRET states.

Positioning
3.9

The score reflects substantial engagement with ADP-inhibition history, ensemble biochemical assays, ε-subunit inhibition, and prior single-molecule rotation work. Positioning is not maximal because the paper only partially addresses how assay-specific constraints such as low ionic strength and detection/classification choices bear on comparability and generalization.

Introduction §1; Discussion §3; Methods §4.1

These biochemical assays using a few ADP/ATP ratios could not discriminate

Reliability

Caveats4 of 4 checks


Internal CoherenceNoted

The central results are internally consistent, but several analysis features limit interpretability at the low-ATP edge and in temporal-rate estimation. The concerns are text-grounded watch-outs rather than contradictions or statistical impossibilities.

Research ConductClean

No text-visible research-conduct concern is apparent for this in vitro enzyme/liposome study. Ethics approval is not evidently required, and the absence of inspected data/code sharing details is treated as an assessability limitation rather than a conduct concern.

Flags: 0 declared / 5 total

Reference IntegrityClean

57 of 57 checkable references verified

57 references in manuscript 2 references confirmed by manual review

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Generic health relevance
Type of advanceMethodological
Route to useNot stated
AdvanceAdvances
CitationsFWCI 0.7
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessControlled
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The mechanism was pinned down in controlled in vitro liposome experiments with defined ADP/ATP mixtures, not in trials or real-world settings.

The paper's only stated uses are further mechanistic research and future technical improvements, with no real-world application of these findings.

Pathway

Biophysicists and biochemists studying ATP synthase regulation would use longer ABEL-trap observations to quantify ADP-inhibition rates, refining bioenergetics models.

Barrier

Observation times of about half a second, limited by photobleaching, are too short to resolve durations of the ADP-inhibited enzyme states.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Platelet-derived factors dysregulate placental sphingosine-1-phosphate receptor 2 in human trophoblasts

    Freya Lyssy, Jacqueline Guettler, Beatrice A Brugger, et al. · 2023 · Basic medicine

    Primary claim

    S1PR2 was found to be significantly down-regulated in BeWo cells when co-incubated with platelet-derived factors (P = 0.0055).

    Tentative
    Evidence Score
    3.1±0.2
    Reliability
    Caveats
  2. The endogenous exposome of the pregnant mother: Placental extracellular vesicles and their effect on the maternal system

    Nadja Kupper, Berthold Huppertz · 2021 · Basic medicine

    Primary claim

    in pregnancy pathologies such as preeclampsia, quantity and quality of the placenta-derived vesicles are altered leading to a deleterious effect on the maternal vascular system.

    Tentative
    Evidence Score
    3.2±0.1
    Reliability
    Caveats
  3. Distinct maternal metabolites are associated with obesity and glucose-insulin axis in the first trimester of pregnancy

    Bandres-Meriz, Kunz, Havelund, et al. · 2023 · Clinical medicine

    Primary claim

    palmitoleoyl ethanolamine (POEA), an endocannabinoid-like lipid endogenously synthesized from palmitoleic acid, and N-acetyl-L-alanine were consistently associated with C-peptide in all the analyses

    Supported
    Evidence Score
    2.6±0.2
    Reliability
    Concerns

How the rubric works →